Iain D. Dukes's Net Worth
$143 Thousand
Who is Iain D. Dukes?
Iain D. Dukes does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Theseus Pharmaceuticals, Inc., IOVANCE BIOTHERAPEUTICS, INC., Ikena Oncology, Inc., and Traws Pharma, Inc..
SEC CIK
Iain D. Dukes's CIK is 0001681955
Past Insider Trading and Trends
2024 was Iain D. Dukes's most active year for acquiring shares with 9 total transactions. Iain D. Dukes's most active month to acquire stocks was the month of May. 2024 was Iain D. Dukes's most active year for disposing of shares, totalling 5 transactions. Iain D. Dukes's most active month to dispose stocks was the month of January. 2024 saw Iain D. Dukes paying a total of $292,800.00 for 4,252,948.622 shares, this is the most they've acquired in one year. In 2024 Iain D. Dukes cashed out on 833,533 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Theseus Pharmaceuticals, Inc. (THRX) No price found
Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -388.32K |
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Snapshot price: $10.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +145.45% | 32K |
$9.15 | $292,800.00 | 54K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +83.33% | 10K |
$6.10 | $61,000.00 | 22K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 12K |
$8.65 | $103,796.40 | 12K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ikena Oncology, Inc. (IKNA) Snapshot price: $1.77
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Traws Pharma, Inc. (TRAW) Snapshot price: $0.3502
Executive Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +101.22% | 67.5K |
—
|
—
| 134.19K |
Apr 1
| |||
Form 4
| +2,670.19% | 1.78M |
—
|
—
| 1.85M |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lomond Therapeutics Holdings, Inc. No price found
CEO and Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||